Skye Bioscience, Inc. - Common Stock, par value $0.001 per share (SKYE)

Historical Holders from Q4 2023 to Q3 2025

Symbol
SKYE on Nasdaq
CUSIP
83086J200
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
31M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
19.9M
Holdings value
$78.1M
% of all portfolios
0.002%
Grand Portfolio weight change
0%
Number of holders
56
Number of buys
21
Number of sells
-32
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Skye Bioscience, Inc. - Common Stock, par value $0.001 per share (SKYE)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
5AM Partners VII, LLC 36.4% $16.5M 11.7M Andrew J. Schwab Dec 17, 2024
SPHERA FUNDS MANAGEMENT LTD. 4.77% $2.08M 1.48M Sphera Funds Management Ltd. Mar 31, 2025
Schonfeld Strategic Advisors LLC 3.6% -32.4% $3.86M -$1.74M 1.12M -31% Schonfeld Strategic Advisors LLC Jun 30, 2025

Institutional Holders of Skye Bioscience, Inc. - Common Stock, par value $0.001 per share (SKYE)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 19.9M $78.1M -$2.1M $3.93 56
2025 Q2 20.4M $85.3M -$12.4M $4.18 54
2025 Q1 24.7M $39.3M -$1.24M $1.59 72
2024 Q4 25.2M $71.3M -$3.22M $2.83 69
2024 Q3 25.7M $101M +$1.21M $3.91 73
2024 Q2 24.5M $196M +$180M $8.01 62
2024 Q1 2.01M $31.4M +$31.4M $15.64 3
2023 Q4 1.6K $4.35K $0 $2.72 1